Corporate News 26-Apr-23
Board of Dhampur Bio Organics recommends final dividend
Of Rs 3.5 per share
Dhampur Bio Organics announced that the Board of Directors of the Company at its meeting held on 25 April 2023, inter alia, have recommended the final dividend of Rs 3.5 per equity Share (i.e. 35%) , subject to the approval of the shareholders.
Previous News
Market trade sideways in early trade; breadth strong
( Market Commentary - Mid-Session 05-Nov-24 09:37 )
Dhampur Bio Organics to conduct AGM
( Corporate News - 02-May-25 16:11 )
Dhampur Bio Organics to convene board meeting
( Corporate News - 28-Mar-25 09:33 )
Stock Alert: IRCTC, Gland Pharma, Tilaknagar Inds, Bata India
( Market Commentary - Stock Alert 05-Nov-24 08:30 )
Dhampur Bio Organics consolidated net profit rises 13.68% in the March 2025 quarter
( Results - Announcements 02-May-25 14:45 )
Dhampur Bio Organics consolidated net profit rises 13.02% in the March 2023 quarter
( Results - Announcements 26-Apr-23 07:38 )
Dhampur Bio tumbles after dismal Q2 performance
( Hot Pursuit - 10-Oct-23 11:11 )
Dhampur Bio Organics schedules board meeting
( Corporate News - 31-Jan-25 11:07 )
Dhampur Bio Organics spurts after Q4 PAT rises 13% YoY to Rs 80 cr
( Hot Pursuit - 26-Apr-23 12:32 )
Dhampur Bio Organics to conduct board meeting
( Corporate News - 29-Apr-25 11:17 )
Dhampur Bio Organics consolidated net profit rises 53.45% in the June 2023 quarter
( Results - Announcements 26-Jul-23 07:38 )
Other Stories
FAST India partners with Indegene to accelerate biotech innovation in India
03-Jul-25 11:01
LMW schedules board meeting
03-Jul-25 09:15
Julien Agro Infratech announces board meeting date
03-Jul-25 09:15
Alembic Pharmaceuticals announces acquisition of Utility Therapeutics
03-Jul-25 09:15
Shriram Asset Mgt. Company schedules AGM
03-Jul-25 09:14
Ideaforge Technology to convene AGM
03-Jul-25 09:14
D-Link (India) to announce Quarterly Result
03-Jul-25 09:14
Tuni Textile Mills to conduct board meeting
03-Jul-25 09:14
Biocon Biologics receives EU marketing authorisation for Vevzuo® and Evfraxy® biosimilars of Denosumab
03-Jul-25 09:12
Shakti Pumps launches QIP issue
03-Jul-25 09:08
Back
Top
